Saxagliptin/dapagliflozin is non‐inferior to insulin glargine in terms of β‐cell function in subjects with latent autoimmune diabetes in adults: A 12‐month, randomized, comparator‐controlled pilot study

Documenti analoghi

• Searching the Crystal Ball for Tailored GLP‐1 Receptor Agonists Treatment in Type 2 Diabetes and Obesity
  di: Asia Saturnino, et al.
  Pubblicazione: (2024)
• LADA 30th anniversary: A growing form of diabetes with persistent unresolved questions
  di: Ivy Lee Jia Jia, et al.
  Pubblicazione: (2024)
• Comparable glycemic outcomes with insulin glargine and insulin degludec during exercise in adolescents with type 1 diabetes using a standardized management protocol
  di: Ivana Rabbone, et al.
  Pubblicazione: (2025)
• Fat Mass Influences Femur Bone Strength and Geometry Parameters, but Not Bone Mineral Density, in Autoimmune Diabetes: A Pilot Study
  di: Renata Risi, et al.
  Pubblicazione: (2026)
• Distributed First Order Logic
  di: Ghidini, Chiara, et al.
  Pubblicazione: (2015)